Skip to main content
NPM1-mutated AML: CD33 SNP rs12459419 predicts relapse in gemtuzumab ozogamicin-treated patients
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
NPM1-mutated AML: CD33 SNP rs12459419 predicts relapse in gemtuzumab ozogamicin-treated patients
User login
Username
Password
Reset your password
Concept
Lead
score
Acute Leukemia
1
1
Acute Myeloblastic Leukemia
0
1
Brachial
0
0.34
Chemotherapy
0
0.17
Grant
0
0.17
Leukemia
0
0.17
Remission
0
0.17
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Pharmacist
0
0.19
Edit Tags